Search

Pages

1. • Journal article

   • 

   Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study.

   Vuylsteke, Peter[UCL] Huizing, M Petrakova, K Roylance, R Laing, R Chan, S Abell, F Gendreau, S Rooney, I Apt, D Zhou, J Singel, S Fehrenbacher, L (2016) Annals of Oncology — Vol. 27, p. 2059-2066 (2016)
2. • Journal article

   • 

   Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study.

   Vuylsteke, Peter[UCL] Huizing, M Petrakova, K Roylance, R Laing, R Chan, S Abell, F Gendreau, S Rooney, I Apt, D Zhou, J Singel, S Fehrenbacher, L (2016) Annals of Oncology — Vol. 27, p. 2059-2066 (2016)
3. • Journal article

   • 

   Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.

   Pulford, David J Harter, Philipp Floquet, Anne Barrett, Catherine Suh, Dong Hoon Friedlander, Michael Arranz, José Angel Hasegawa, Kosei Tada, Hiroomi Vuylsteke, Peter[UCL] Mirza, Mansoor R Donadello, Nicoletta Scambia, Giovanni Johnson, Toby Cox, Charles Chan, John K Imhof, Martin Herzog, Thomas J Calvert, Paula Wimberger, Pauline Berton-Rigaud, Dominique Lim, Myong Cheol Elser, Gabriele Xu, Chun-Fang du Bois, Andreas (2016) BMC Medical Ethics — Vol. 17, no.1, p. 63 (2016)
4. • Journal article

   • 

   ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.

   Marth, Christian Vergote, Ignace Scambia, Giovanni Oberaigner, Willi Clamp, Andrew Berger, Regina Kurzeder, Christian Colombo, Nicoletta Vuylsteke, Peter[UCL] Lorusso, Domenica Hall, Marcia Renard, Vincent Pignata, Sandro Kristeleit, Rebecca Altintas, Sevilay Rustin, Gordon Wenham, Robert M Mirza, Mansoor Raza Fong, Peter C Oza, Amit Monk, Bradley J Ma, Haijun Vogl, Florian D Bach, Bruce A (2017) European Journal of Cancer — Vol. 70, p. 111-121 (2017)
5. • Journal article

   • 

   70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

   Cardoso, Fatima van't Veer, Laura J Bogaerts, Jan Slaets, Leen Viale, Giuseppe Delaloge, Suzette Pierga, Jean-Yves Brain, Etienne Causeret, Sylvain DeLorenzi, Mauro Glas, Annuska M Golfinopoulos, Vassilis Goulioti, Theodora Knox, Susan Matos, Erika Meulemans, Bart Neijenhuis, Peter A Nitz, Ulrike Passalacqua, Rodolfo Ravdin, Peter Rubio, Isabel T Saghatchian, Mahasti Smilde, Tineke J Sotiriou, Christos Stork, Lisette Straehle, Carolyn Thomas, Geraldine Thompson, Alastair M van der Hoeven, Jacobus M Vuylsteke, Peter[UCL] Bernards, René Tryfonidis, Konstantinos Rutgers, Emiel Piccart, Martine MINDACT Investigators (2016) New England Journal of Medicine — Vol. 375, no. 8, p. 717-729 (2016)
6. • Journal article

   • 

   Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer

   Mardjuadi, Feby[UCL] Carrasco, Javier[UCL] Coche, Jean-Charles Sempoux, Christine[UCL] Jouret-Mourin, Anne[UCL] Scalliet, Pierre[UCL] Goeminne, Jean-Charles Daisne, Jean-François Delaunoit, Thierry Vuylsteke, Peter Humblet, Yves[UCL] Meert, Nicolas Van den Eynde, Marc[UCL] Moxhon, Anne[UCL] Haustermans, Karin Canon, Jean-Luc[UCL] Machiels, Jean-Pascal[UCL] (2015) Targeted Oncology : biotherapies for the clinicians in oncology — Vol. 10, no. 3, p. 375-383 (2015)
7. • Speech

   • 

   Combination of paclitaxel and LAG3-Ig (IMP321), a novel MHC class II agonist, as a first-line chemoimmunotherapy in patients with metastatic breast carcinoma (MBC): interim results from the run-in phase of a placebo controlled randomized phase II

   Duhoux, François[UCL] Jager, Agnes Dirix, Luc Huizing, Manon Jerusalem, Guy Vuylsteke, Peter[UCL] De Cuypere, Eveline Breiner, Doris Mueller, Christian[UCL] Brignone, Chrystelle Triebel, Frederic[UCL] (2017) Annual Meeting of the American Society of Clinical Oncology (ASCO) — Chicago, IL, USA
8. • Journal article

   • 

   Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

   Colleoni, Marco Luo, Weixiu Karlsson, Per Chirgwin, Jacquie Aebi, Stefan Jerusalem, Guy Neven, Patrick Hitre, Erika Graas, Marie-Pascale Simoncini, Edda Kamby, Claus Thompson, Alastair Loibl, Sibylle Gavilá, Joaquín Kuroi, Katsumasa Marth, Christian Müller, Bettina O'Reilly, Seamus Di Lauro, Vincenzo Gombos, Andrea Ruhstaller, Thomas Burstein, Harold Ribi, Karin Bernhard, Jürg Viale, Giuseppe Maibach, Rudolf Rabaglio-Poretti, Manuela Gelber, Richard D Coates, Alan S Di Leo, Angelo Regan, Meredith M Goldhirsch, Aron SOLE Investigators Vuylsteke, Peter[UCL] (2018) The Lancet. Oncology — Vol. 19, no. 1, p. 127-138 (2018)
9. • Journal article

   • 

   Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group

   Vergote, Ignace Debruyne, Philippe Kridelka, Frédéric Berteloot, Patric Amant, Frédéric Honhon, Brigitte Lybaert, Willem Leunen, Karin Geldhof, Kurt Verhoeven, Didier Forget, Frédéric Vuylsteke, Peter D'Hondt, Lionel[UCL] Huizing, Manon Van Den Bulck, Heidi Laenen, Annouschka (2015) Gynecologic Oncology — Vol. 138, no. 2, p. 278-284 (2015)
10. • Journal article

    • 

    Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Baselga, José Im, Seock-Ah Iwata, Hiroji Cortés, Javier De Laurentiis, Michele Jiang, Zefei Arteaga, Carlos L Jonat, Walter Clemons, Mark Ito, Yoshinori Awada, Ahmad Chia, Stephen Jagiełło-Gruszfeld, Agnieszka Pistilli, Barbara Tseng, Ling-Ming Hurvitz, Sara Masuda, Norikazu Takahashi, Masato Vuylsteke, Peter[UCL] Hachemi, Soulef Dharan, Bharani Di Tomaso, Emmanuelle Urban, Patrick Massacesi, Cristian Campone, Mario (2017) The Lancet Oncology — Vol. 18, no.7, p. 904-916 (2017)
11. • Journal article

    • 

    Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.

    Wildiers, Hans Tryfonidis, Konstantinos Dal Lago, Lissandra Vuylsteke, Peter[UCL] Curigliano, Giuseppe Waters, Simon Brouwers, Barbara Altintas, Sevilay Touati, Nathan Cardoso, Fatima Brain, Etienne (2018) The Lancet. Oncology — Vol. 19, no. 3, p. 323-336 (2018)
12. • Journal article

    • 

    Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.

    Neven, Patrick Jongen, Lynn Lintermans, Anneleen Van Asten, Kathleen Blomme, Chantal Lambrechts, Diether Poppe, An Wildiers, Hans Dieudonné, Anne-Sophie Brouckaert, Olivier Decloedt, Jan Berteloot, Patrick Verhoeven, Didier Joerger, Markus Vuylsteke, Peter[UCL] Wynendaele, Wim Casteels, Minne Van Huffel, Sabine Lybaert, Willem Van Ginderachter, Johan Paridaens, Robert Vergote, Ignace Dezentjé, Vincent Olaf Van Calster, Ben Guchelaar, Henk-Jan (2018) Clinical cancer research : an official journal of the American Association for Cancer Research — Vol. 24, no. 10, p. 2312-2318 (2018)
13. • Journal article

    • 

    The added value of geriatric assessment in evaluating a patient's Health-Related Quality-of-Life: A study in ≥70-year-old early-stage invasive breast cancer patients.

    Quinten, Chantal Kenis, Cindy Hamaker, Marije Coolbrandt, Annemarie Brouwers, Barbara Dal Lago, Lissandra Neven, Patrick Vuylsteke, Peter[UCL] Debrock, Guy Van Den Bulck, Heidi Smeets, Ann Schöffski, Patrick Wedding, Ulrich Wildiers, Hans (2020) European journal of cancer care — Vol. 29, no.5, p. e13278 [1-10] (2020)
14. • Journal article

    • 

    European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment.

    Derksen, Jeroen W G Warren, Graham W Jordan, Karin Rauh, Stefan Vera García, Ruth O'Mahony, Deirdre Ahmed, Samreen Vuylsteke, Peter[UCL] Radulovic, Sinisa Tsoukalas, Nikolaos Wysocki, Piotr J Borner, Markus Cesas, Alvydas Elme, Anneli Minn, Heikki Ullenhag, Gustav J Roodhart, Jeanine M L Koopman, Miriam May, Anne M (2020) European journal of cancer — Vol. 138, p. 99-108 (2020)
15. • Journal article

    • 

    MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.

    Monk, Bradley J Grisham, Rachel N Banerjee, Susana Kalbacher, Elsa Mirza, Mansoor Raza Romero, Ignacio Vuylsteke, Peter[UCL] Coleman, Robert L Hilpert, Felix Oza, Amit M Westermann, Anneke Oehler, Martin K Pignata, Sandro Aghajanian, Carol Colombo, Nicoletta Drill, Esther Cibula, David Moore, Kathleen N Christy-Bittel, Janna Del Campo, Josep M Berger, Regina Marth, Christian Sehouli, Jalid O'Malley, David M Churruca, Cristina Boyd, Adam P Kristensen, Gunnar Clamp, Andrew Ray-Coquard, Isabelle Vergote, Ignace (2020) Journal of clinical oncology — Vol. 38, no.32, p. 3753-3762 (2020)
16. • Journal article

    • 

    Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study.

    Wu, Qi Brouwers, Barbara Dalmasso, Bruna Kenis, Cindy Vuylsteke, Peter[UCL] Debrock, Guy Smeets, Ann Laenen, Annouschka Wildiers, Hans Hatse, Sigrid (2022) Translational oncology — Vol. 25, p. 101527 (2022)
17. • Journal article

    • 

    Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression.

    Wildiers, Hans Meyskens, Thomas Marréaud, Sandrine Lago, Lissandra Dal Vuylsteke, Peter[UCL] Curigliano, Giuseppe Waters, Simon Brouwers, Barbara Meulemans, Bart Sousa, Berta Poncet, Coralie Brain, Etienne (2022) Breast (Edinburgh, Scotland) — Vol. 64, p. 100-111 (2022)
18. • Journal article

    • 

    Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.

    van Marcke, Cédric[UCL] Helaers, Raphaël[UCL] De Leener, Anne[UCL] Merhi, Ahmad[UCL] Schoonjans, Céline Ambroise, Jérôme[UCL] Galant, Christine[UCL] Delrée, Paul Rothé, Françoise Bar, Isabelle Khoury, Elsa[UCL] Brouillard, Pascal[UCL] Canon, Jean-Luc Vuylsteke, Peter[UCL] Machiels, Jean-Pascal[UCL] Berliere, Martine[UCL] Limaye, Nisha[UCL] Vikkula, Miikka[UCL] Duhoux, François[UCL] (2020) Breast cancer research — Vol. 22, no. 1, p. 36 (2020)
19. • Journal article

    • 

    Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial.

    Delaloge, Suzette Piccart, Martine Rutgers, Emiel Litière, Saskia van 't Veer, Laura J van den Berkmortel, Franchette Brain, Etienne Dudek-Peric, Aleksandra Gil-Gil, Miguel Gomez, Patricia Hilbers, Florentine S Khalil, Zaman Knox, Susan Kuemmel, Sherko Kunz, Georg Lesur, Anne Pierga, Jean-Yves Ravdin, Peter Rubio, Isabel T Saghatchian, Mahasti Smilde, Tineke J Thompson, Alastair M Viale, Giuseppe Zoppoli, Gabriele Vuylsteke, Peter[UCL] Tryfonidis, Konstantinos Poncet, Coralie Bogaerts, Jan Cardoso, Fatima MINDACT investigators and the TRANSBIG Consortium (2020) Journal of clinical oncology — Vol. 38, no. 11, p. 1186-1197 (2020)
20. • Journal article

    • 

    Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.

    Gómez-Aleza, Clara Nguyen, Bastien Yoldi, Guillermo Ciscar, Marina Barranco, Alexandra Hernández-Jiménez, Enrique Maetens, Marion Salgado, Roberto Zafeiroglou, Maria Pellegrini, Pasquale Venet, David Garaud, Soizic Trinidad, Eva M Benítez, Sandra Vuylsteke, Peter[UCL] Polastro, Laura Wildiers, Hans Simon, Philippe Lindeman, Geoffrey Larsimont, Denis Van den Eynden, Gert Velghe, Chloé Rothé, Françoise Willard-Gallo, Karen Michiels, Stefan Muñoz, Purificación Walzer, Thierry Planelles, Lourdes Penninger, Josef Azim, Hatem A Loi, Sherene Piccart, Martine Sotiriou, Christos González-Suárez, Eva (2020) Nature communications — Vol. 11, no.1, p. 6335 [1-18] (2020)
21. • Journal article

    • 

    Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

    Saura, Cristina Hlauschek, Dominik Oliveira, Mafalda Zardavas, Dimitrios Jallitsch-Halper, Anita de la Peña, Lorena Nuciforo, Paolo Ballestrero, Alberto Dubsky, Peter Lombard, Janine M Vuylsteke, Peter[UCL] Castaneda, Carlos A Colleoni, Marco Santos Borges, Giuliano Ciruelos, Eva Fornier, Monica Boer, Katalin Bardia, Aditya Wilson, Timothy R Stout, Thomas J Hsu, Jerry Y Shi, Yi Piccart, Martine Gnant, Michael Baselga, José de Azambuja, Evandro (2019) The Lancet. Oncology — Vol. 20, no.9, p. 1226-1238 (2019)
22. • Journal article

    • 

    Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO).

    Fontaine, Christel Renard, Vincent Van den Bulk, Heidi Vuylsteke, Peter[UCL] Glorieux, Philip Dopchie, Catherine Decoster, Lore Vanacker, Leen de Azambuja, Evandro De Greve, Jacques Awada, Ahmad Wildiers, Hans (2019) Breast cancer research and treatment — Vol. 176, no. 3, p. 607-615 (2019)
23. • Journal article

    • 

    PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.

    Tuyaerts, Sandra Van Nuffel, An M T Naert, Eline Van Dam, Peter A Vuylsteke, Peter[UCL] De Caluwé, Alex Aspeslagh, Sandrine Dirix, Piet Lippens, Lien De Jaeghere, Emiel Amant, Frédéric Vandecasteele, Katrien Denys, Hannelore (2019) BMC cancer — Vol. 19, no. 1, p. 506 [1-10] (2019)
24. • Journal article

    • 

    The genomic landscape of nonsmall cell lung carcinoma in never smokers.

    Boeckx, Bram Shahi, Rajendra B Smeets, Dominiek De Brakeleer, Sylvia Decoster, Lore Van Brussel, Thomas Galdermans, Daniella Vercauter, Piet Decoster, Lynn Alexander, Patrick Berchem, Guy Ocak, Sebahat[UCL] Vuylsteke, Peter[UCL] Deschepper, Koen Lambrechts, Marc Cappoen, Nadia Teugels, Erik Lambrechts, Diether De Greve, Jacques (2020) International journal of cancer — Vol. 146, no. 11, p. 3207-3218 (2020)
25. • Speech

    • 

    Tumor sequencing is useful to reclassify germline variants in unexplained high-risk breast cancer

    van Marcke, Cédric[UCL] Helaers, Raphaël[UCL] Schoonjans, Céline[UCL] Berlière, Martine[UCL] De Leener, Anne[UCL] canon, Jean-Luc Vuylsteke, Peter[UCL] Machiels, Jean-Pascal[UCL] Limaye, Nisha[UCL] Vikkula, Miikka[UCL] Duhoux, François[UCL] (2019) San Antonio Breast Cancer Symposium — San Antonio

Pages